News

June 22, 2025 |

News Releases

ProSciento Presents Two Scientific Posters at the 2025 American Diabetes Association (ADA) Scientific Sessions

June 18, 2025 |

News Releases

ProSciento Announces Publication on the Global Burden of MASLD and MASH by Contributors of the Metabolic Continuum Roundtable

October 25, 2024 |

News Releases

ProSciento Appoints Janet Reardon as Vice President of People

August 15, 2024 |

News Releases

ProSciento Celebrates 20 Years of Support for the American Diabetes Association

February 1, 2024 |

News Releases

ProSciento Announces Publication on AI-Assisted Digital Pathology for MASH by Contributors of the Metabolic Continuum Roundtable

November 11, 2023 |

News Releases

ProSciento Hosts 7th Metabolic Continuum Roundtable Forum, Advancing Cross-Disciplinary Collaboration in Metabolic Disease Research

October 17, 2023 |

News Releases

ProSciento Receives 2023 Innovation Award from The Liver Coalition of San Diego

September 16, 2023 |

News Releases

ProSciento Prepares to ‘Step Out’ Against Diabetes as a Sponsor for the American Diabetes Association Event in Southern California for a 19th Year

September 1, 2023 |

News Releases

ProSciento to Present Patient Access & Engagement (PAE) at the NASH Paris Meeting 2023

June 24, 2023 |

News Releases

New Liver Disease Nomenclature Announced

February 1, 2023 |

News Releases

ProSciento Appoints David Sockolof as Chief Financial Officer

October 31, 2022 |

News Releases

ProSciento Hosts 6th NASH Roundtable Forum in Washington, DC

September 15, 2022 |

News Releases

ProSciento to Present NASH PASS® Registry Data at EASL NAFLD Summit 2022

September 10, 2022 |

News Releases

ProSciento Prepares to ‘Step Out’ Against Diabetes as the Living Red Sponsor for the American Diabetes Association Fundraising Event in Southern California

June 7, 2022 |

News Releases

ProSciento Hosts the 5th NASH Roundtable Virtual Forum Focused on Digital Pathology for Histology in NASH Drug Development

May 23, 2022 |

News Releases

ProSciento Appoints Dr. Michelle Mazuranic as Vice President of Medical and Regulatory Affairs

December 10, 2021 |

News Releases

Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum

November 30, 2021 |

News Releases

ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks

November 10, 2021 |

News Releases

ProSciento Appoints Lynn Rudolph as Vice President of Human Resources

November 1, 2021 |

News Releases

ProSciento Co-Hosts the 4th Annual NASH Roundtable Virtual Forum

July 8, 2021 |

News Releases

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science

September 10, 2020 |

News Releases

ProSciento Closes Growth Financing from 1315 Capital

September 1, 2020 |

News Releases

ProSciento Appoints Stephen Mullennix as Chief Financial Officer

June 15, 2020 |

News Releases

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California

February 6, 2020 |

News Releases

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)

November 12, 2019 |

News Releases

ProSciento to Present at the Diabetes Technology Annual Meeting

August 5, 2019 |

News Releases

ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting

June 17, 2019 |

News Releases

ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer

May 29, 2019 |

News Releases

ProSciento to Present at the American Diabetes Association 79th Scientific Sessions

April 15, 2019 |

News Releases

ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit

April 10, 2019 |

News Releases

Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research

March 19, 2019 |

News Releases

ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna

January 2, 2019 |

News Releases

ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference

December 5, 2018 |

News Releases

ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs

October 26, 2018 |

News Releases

ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting

September 27, 2018 |

News Releases

ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting

August 6, 2018 |

News Releases

ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer

June 21, 2018 |

News Releases

ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials

June 19, 2018 |

News Releases

ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team

June 13, 2018 |

News Releases

ProSciento to Present at the American Diabetes Association 78th Scientific Sessions

April 19, 2018 |

News Releases

ProSciento Presents Scientific Data at the 2nd Annual Nash Summit

March 7, 2018 |

News Releases

ProSciento Expands Asia Pacific Operations with Office in Australia

November 6, 2017 |

News Releases

ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit

September 9, 2017 |

News Releases

ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon

June 7, 2017 |

News Releases

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

June 6, 2017 |

News Releases

ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego

May 1, 2017 |

News Releases

ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop

February 15, 2017 |

News Releases

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population

September 14, 2016 |

News Releases

ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research

July 28, 2016 |

News Releases

ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH

June 10, 2016 |

News Releases

ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism

June 9, 2016 |

News Releases

ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions

June 6, 2016 |

News Releases

ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans

April 5, 2016 |

News Releases

ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego

November 9, 2015 |

News Releases

Congratulations to Hanmi Pharmaceutical Co., Ltd.

October 29, 2015 |

News Releases

ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego

October 28, 2015 |

News Releases

ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research

October 28, 2015 |

News Releases

ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH

October 13, 2015 |

News Releases

ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

October 8, 2015 |

News Releases

ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development

September 10, 2015 |

News Releases

ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting

June 4, 2015 |

News Releases

ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership

May 29, 2015 |

News Releases

ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston

May 7, 2015 |

News Releases

ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt

April 15, 2015 |

News Releases

ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego

January 22, 2015 |

News Releases

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods

Get in Touch

ProSciento Presents Two Scientific Posters at the 2025 American Diabetes Association (ADA) Scientific Sessions

ProSciento Appoints Megan McCormick as Chief Operating Officer

ProSciento Celebrates 18 Years of Support for Breakthrough T1D

Q&A: The Critical Role of Nutrition in Metabolic Clinical Research

ProSciento Announces Publication on the Global Burden of MASLD and MASH by Contributors of the Metabolic Continuum Roundtable

ProSciento Appoints Janet Reardon as Vice President of People

ProSciento Celebrates 20 Years of Support for the American Diabetes Association

ProSciento Announces Publication on AI-Assisted Digital Pathology for MASH by Contributors of the Metabolic Continuum Roundtable

ProSciento Hosts 7th Metabolic Continuum Roundtable Forum, Advancing Cross-Disciplinary Collaboration in Metabolic Disease Research

ProSciento Receives 2023 Innovation Award from The Liver Coalition of San Diego

ProSciento Prepares to ‘Step Out’ Against Diabetes as a Sponsor for the American Diabetes Association Event in Southern California for a 19th Year

ProSciento to Present Patient Access & Engagement (PAE) at the NASH Paris Meeting 2023

New Liver Disease Nomenclature Announced

ProSciento Appoints David Sockolof as Chief Financial Officer

ProSciento Hosts 6th NASH Roundtable Forum in Washington, DC

ProSciento to Present NASH PASS® Registry Data at EASL NAFLD Summit 2022

ProSciento Prepares to ‘Step Out’ Against Diabetes as the Living Red Sponsor for the American Diabetes Association Fundraising Event in Southern California

ProSciento Hosts the 5th NASH Roundtable Virtual Forum Focused on Digital Pathology for Histology in NASH Drug Development

ProSciento Appoints Dr. Michelle Mazuranic as Vice President of Medical and Regulatory Affairs

Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum

ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks

ProSciento Appoints Lynn Rudolph as Vice President of Human Resources

ProSciento Co-Hosts the 4th Annual NASH Roundtable Virtual Forum

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science

ProSciento Closes Growth Financing from 1315 Capital

ProSciento Appoints Stephen Mullennix as Chief Financial Officer

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)

ProSciento to Present at the Diabetes Technology Annual Meeting

ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting

ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer

ProSciento to Present at the American Diabetes Association 79th Scientific Sessions

ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit

Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research

ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna

ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference

ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs

ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting

ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting

ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer

ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials

ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team

ProSciento to Present at the American Diabetes Association 78th Scientific Sessions

ProSciento Presents Scientific Data at the 2nd Annual Nash Summit

ProSciento Expands Asia Pacific Operations with Office in Australia

ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit

ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego

ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population

ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research

ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH

ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism

ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions

ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans

ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego

Congratulations to Hanmi Pharmaceutical Co., Ltd.

ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego

ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research

ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH

ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development

ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting

ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership

ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston

ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt

ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods